Southwest reported Q1 2026 adjusted EPS of $0.45, meeting the guided floor despite a $0.22/share fuel headwind. RASM grew +11.2% YoY — 170bp above the +9.5% guide. Operating margin expanded 8.1 points YoY to 4.6%, which management described as the highest adjusted net margin among large U.S. airlines in the quarter. The customer buy-up rate — the share of passengers purchasing above the base product — jumped from ~20% in 2025 to ~60% in Q1 2026, with Watterson noting “at least half of that came from people voluntarily decided to pay more.” All three decisive datapoints from the March analysis landed favorable.
The Numbers
Four Signal Upgrades
Forecast Market Resolutions
Fuel Is the Remaining Swing Factor
Q1 fuel averaged $2.73/gallon against $2.40 guidance — $164M incremental cost, $0.22/share headwind. Southwest remains unhedged after discontinuing its fuel hedging program (prior cost: ~$150M/year in hedging losses). Q2 2026 fuel assumption is $4.10-4.15/gal per the April 16 forward curve — materially higher than Q1 actual.
Full-year $4.00 EPS guide was maintained, but Jordan explicitly conditioned it on “lower fuel prices and/or stronger revenue performance to offset higher fuel expense.” Jordan: “the short story is, but for fuel, everything is on track. It’s really just a story of fuel.”
Q2 Guide: Industry-Leading
Management guided Q2 RASM growth of +16.5% to +18.5% YoY — Watterson called it “industry-leading by a wide margin.” CASM-X +3.5-4.0% on 0.5% capacity growth. EPS $0.35-0.65 at $4.10-4.15/gal fuel assumption. The 5 broad industry-wide fare moves since March 1, with all competitors following, provide a supportive pricing backdrop.
If Q2 matches or exceeds the guide, the transformation reaches a mature-proven stage — two consecutive quarters validate the revenue model across a full demand cycle. If Q2 misses, the Q1 result may be reread as a one-time spike driven by fare-move timing rather than structural gain.
Posture Shift: PROCEED_WITH_CAUTION → CAUTIOUS_CONSTRUCTIVE
The March analysis articulated a 2-3 year patient-investor case conditional on transformation execution. Q1 has substantially shortened the uncertainty window. Balance sheet strengthened through the transformation — liquidity improved from $3.2B to $4.8B, leverage improved from 2.4x to 2.2x, investment-grade rating preserved.
Near-term risk concentrates in fuel volatility, not transformation execution. Ongoing monitoring: Q2 RASM delivery (July earnings), fuel path, FY $4 EPS guide integrity, and Elliott 13F activity for any reduction signaling capital rotation.